Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

KRX/003060 stock hub

KRX/003060 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KRX/003060is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

45.8B

Korea Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

KRX/003060

In the news

Latest news · KRX/003060

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.8P50 17.1P75 31.9

Trailing P/En/a

P25 12P50 23.1P75 39.5

ROE-51.3

P25 -17.1P50 0.7P75 8.5

ROIC-26.9

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KRX/003060 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

183

Groups with data

Currency

KRW

Showing 183 of 183 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	391
Enterprise value	KRW 292.8B
Exchange	Korea Stock Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	KR7003060001
Last refreshed	2026-05-10
Market cap	KRW 45.8B
Price	KRW 3,480
Price currency	KRW
Rev Per Employee	187,279,130.84x
Sector	Healthcare
Sic	2834
Symbol	krx/003060
Website	https://en.aprogen-pharm.com/index.do

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-371.6%
EV Earnings	-1.72x
EV/FCF	-6.12x
EV/Sales	4x
FCF yield	-104.41%
P/B ratio	0.17x
P/S ratio	0.63x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-167.82%
EBITDA Margin	-141.62%
Gross margin	-37.36%
Gross Profit	KRW -27.4B
Net Income	KRW -170.3B
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-231.31%
Profit Margin	-232.61%
Profit Per Employee	KRW -435.6M
ROA	-13.04
Roa5y	-5.4
ROCE	-34.34
ROE	-51.29
Roe5y	-20.33
ROIC	-26.88
Roic5y	-10.37

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-38.19%
Cagr15y	-21.73%
Cagr1y	-66.01%
Cagr20y	-25.96%
Cagr3y	-58.02%
Cagr5y	-51.82%
EPS Growth Quarters	1
EPS Growth Years	2
Revenue Growth	8.68x
Revenue Growth Q	-7.64x
Revenue Growth Years	1x
Revenue Growth3 Y	3.95x
Revenue Growth5 Y	6.55x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.12
Assets	KRW 587B
Cash	KRW 51.6B
Current Assets	KRW 154.5B
Current Liabilities	KRW 229.1B
Debt	KRW 228.8B
Debt Equity	KRW 0.82
Debt FCF	KRW -4.78
Equity	KRW 277.6B
Interest Coverage	-11.49
Liabilities	KRW 309.4B
Long Term Assets	KRW 432.5B
Long Term Liabilities	KRW 80.3B
Net Cash	KRW -177.2B
Net Cash By Market Cap	KRW -387
Net Debt Equity	KRW 0.64
Tangible Book Value	KRW 202.5B
Tangible Book Value Per Share	KRW 15,364
WACC	3.63

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.67
Inventory Turnover	1.94
Net Working Capital	KRW 43.9B
Quick ratio	0.32
Working Capital	KRW -74.6B
Working Capital Turnover	KRW -1.37

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-57.17%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.19%
1Y total return	-65.98%
200-day SMA	8,019.3
3Y total return	-92.61%
50-day SMA	5,212
50-day SMA vs 200-day SMA	50under200
5Y total return	-97.4%
All Time High	43,111,750.3
All Time High Change	-99.99%
All Time High Date	2001-10-16
All Time Low	3,405
All Time Low Change	2.2%
All Time Low Date	2026-04-09
ATR	463.8
Beta	-0.17
Beta1y	0.13
Beta2y	0.32
Ch YTD	-55.3
High	4,270
High52	10,770
High52 Date	2025-06-10
High52ch	-67.69%
Low	3,450
Low52	3,405
Low52 Date	2026-04-09
Low52ch	2.2%
Ma50ch	-33.23%
Price vs 200-day SMA	-56.6%
RSI	32.77
RSI Monthly	23.3
RSI Weekly	25.42
Sharpe ratio	-1.96x
Sortino ratio	-2.81
Total Return	-57.17%
Tr YTD	-55.3
Tr15y	-97.47%
Tr1m	-1.28%
Tr1w	-0.14%
Tr3m	-51.16%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW -122.9B
Operating margin	-167.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5,055,406%
Net Borrowing	135,136,315,550
Shares Insiders	0.01%
Shares Institutions	0.55%
Shares Out	13,171,521
Shares Qo Q	0.05%
Shares Yo Y	57.17%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -47.9B
Average Volume	282,262.05x
Bv Per Share	15,764.8
CAPEX	KRW -9.6B
Ch10y	-99.59
Ch15y	-98.71
Ch1m	-1.28
Ch1w	-0.14
Ch1y	-65.98
Ch20y	-99.89
Ch3m	-51.16
Ch3y	-94.38
Ch5y	-98.03
Ch6m	-58.57
Change	0%
Change From Open	-13
Depreciation Amortization	19,184,604,340
Dollar Volume	1,605,494,520
Earnings Date	2026-05-13
EBIT	KRW -122.9B
EBITDA	KRW -103.7B
EPS	KRW -12,930
F Score	2
FCF	KRW -47.9B
FCF EV Yield	-16.34x
FCF Per Share	KRW -3,633
Financing CF	135,136,838,640
Fiscal Year End	December
Founded	1,960
Income Tax	KRW -1.1B
Investing CF	-85,119,227,840
Is Primary Listing	1
Last Earnings Date	2025-11-13
Last Report Date	2025-12-31
Last Split Date	2026-04-13
Last Split Type	Reverse
Ma150	7,498.6
Ma150ch	-53.59%
Ma20	4,195
Ma20ch	-17.04%
Net CF	12,086,366,740
Next Earnings Date	2026-05-13
Open	4,000
Position In Range	3.66
Ppne	322,533,180,940
Price Date	2026-05-08
Ptbv Ratio	0.23
Relative Volume	1.63x
Revenue	73,226,140,160x
Tax By Revenue	-1.48x
Tr20y	-99.76%
Tr6m	-58.57%
Volume	461,349
Z Score	-1.44

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does KRX/003060 pay a dividend?

Capital-return profile for this ticker.

Performance

KRX/003060 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KRX/003060?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.5%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+57.2%

Negative means the company is buying back shares.

Technical

KRX/003060 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

32.8

Neutral momentum band

Price vs 200-day MA

-56.6%

50/200-day relationship not available

Beta (5Y)

-0.17

Less volatile than the market

Sharpe ratio

-1.96

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KRX/003060

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/003060 stock rating?

krx/003060 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/003060 analysis?

The full report lives at /stocks/krx/003060/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/003060?

The latest report frames krx/003060 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/003060 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.